|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00314 SIPAI HEALTH
Nominal 
1.590 +0.010 (+0.633%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 739,916 | -39.553% | 2,070,984 | 4,565,434 | 4,712,107 | 4,119,478 |
| Cost of Sales | (591,384) | -43.568% | (1,759,659) | (4,179,001) | (4,297,409) | (3,782,126) |
| Gross Profit | 148,532 | -15.654% | 311,325 | 386,433 | 414,698 | 337,352 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (2,081) | -19.435% | (9,662) | (35,299) | (9,965) | (780,726) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | (7,489) | -44.620% | (17,926) | (22,295) | -- | -- | |
| Share of Results of Asso. & JCEs | (72) | 24.138% | (60) | (187) | (412) | 331 | |
| Profit / (Loss) before Taxation | 43,608 | -- | (128,156) | (360,641) | (245,666) | (1,368,442) | |
| Taxation | (684) | -- | 1,378 | (1,191) | (1,041) | (3,322) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 370 | -95.958% | 2,511 | 38,096 | (9,061) | 1,192 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 43,294 | -- | (124,267) | (323,736) | (255,768) | (1,370,572) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (1,584) | -63.223% | (6,862) | (12,752) | (27,851) | (13,208) |
| Depreciation & Amortisation | 10,144 | -34.364% | 26,884 | 48,775 | 52,968 | 49,423 |
| Directors' Emoluments | -- | -- | 4,952 | 5,081 | 5,783 | 137,580 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 7.000 | -- | -21.000 | -51.000 | -40.000 | -1,219.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.011 | (0.093) | (0.207) | (1.619) |
| NBV per share ($) | 1.280 | -- | 1.249 | 1.604 | 2.126 | 2.407 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 43,294 |
| %Change | -- |
| EPS / (LPS) | RMB 0.070 |
| NBV Per Share (¥) | RMB 1.280 |